Markers of endothelial dysfunction

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 2, 2000, Pages 77-85

  Müller, Mathias M ^a   Griesmacher, Andrea ^a  

^a KAISER FRANZ JOSEF HOSPITAL   (Austria)

Author keywords

Atherosclerosis; Coagulation; Endothelial dysfunction; Immune response; Vascular tone

Indexed keywords

ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD VESSEL TONE; CONFERENCE PAPER; DISEASE MARKER; HEMOSTASIS; IMMUNE RESPONSE; PATHOGENESIS; PRIORITY JOURNAL; THROMBOGENESIS; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0034107678     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.013     Document Type: Conference Paper

References (44)

1. Gimbrone MA Jr. Vascular endothelium: Nature's blood container. In: Gimbrone MA Jr (ed.). Vascular endothelium in hemostasis and thrombosis. Edinburgh: Churchill Livingstone, 1986, pp. 1-13.
2. Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Ann Rev Med 1996; 47:315-31.
3. Cines DB, Pollak, ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91:3527-61.
4. Ross R, Glomset JA. The pathogenesis of atherosclerosis. New Engl J Med 1976; 295:369-77.
5. Gimbrone MA Jr. Endothelial dysfunction and the pathogenesis of atherosclerosis. In: Fidge NH, Nestel PJ (eds). Atherosclerosis VII. Proceedings of the 7th International Symposium on Atherosclerosis. Amsterdam: Excerpta Medica, 1986, pp. 367-9.
6. Simionescu N, Simionescu M (eds). Endothelial cell dysfunctions. New York, Plenum Press, 1992.
7. Ross R. The pathogenesis of artherosclerosis: a perspective for 1990's. Nature 1993; 362:801-9.
8. Gimbrone MA Jr: Atherogenesis: Current concepts. In: Schoen FJ, Gimbrone MA Jr (eds). Cardiovascular pathology: clinical pathologic correlations and pathogenetic mechanisms. Baltimore: Williams and Wilkins, 1995, pp. 1-11.
9. Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995; 25:155-61.
10. Moncada S, Vane JR. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull 1978; 34:129-35.
11. Griesmacher A, Weigel G, David M, Schimke I, Müller MM. Influence of oxygen radicals generating agents on eicosanoid metabolism of human endothelial cells. Thromb Res 1992; 65:721-31.
12. Schimke I, Griesmacher A, Weigel G, Holzhutter HG, Müller MM. Effects of reactive oxygen species on eicosanoid metabolism in human endothelial cells. Prostaglandins 1992;43:281-92.
13. 2+ on prostaglandin I2 and thromboxane A2 synthesis by human endothelial cells. Arterioscler Thromb 1992; 12:512-8.
14. Tihan T, Chiba P, Krupicka O, Fritzer M, Seitelberger R, Müller MM. Serum lipid peroxide levels in the course of coronary by-pass surgery. Eur J Clin Chem Clin Biochem 1992; 30:205-8.
15. Akimova EV. Prostacyclin and thromboxane A2 levels in children and adolescents with an inherited predisposition to coronary heart disease: a family study. Coron Artery Dis 1994; 5:761-5.
16. Todd J, Lawrenson R, Farmer RD, Williams TJ, Leydon GM. Venous thromboembolic disease and combined oral contraceptives: a re-analysis of the MediPlus database. Hum Reprod 1999; 14:1500-5.
17. David M, Griesmacher A, Müller MM. 17-alpha-ethinyl-estradiol decreases production and release of prostacyclin in cultured human umbilical vein endothelial cells. Prostaglandins 1989; 38:431-8.
18. Havel MP, Griesmacher A, Weigel G, Owen A, Simon P, Teufelsbauer H, et al. Aprotinin increases release of von Willebrand factor in cultured human umbilical vein endothelial cells. Surgery 1992; 112:573-7.
19. Galatius S, Wroblewski H, Sorensen VB, Bie P, Parving HH, Kastrup J. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation? Am Heart J 1999; 137:549-54.
20. Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler Thromb Vasc Biol 1995; 15:1114-20.
21. Blann AD, Lip GY, Beevers DG, McCollum CN. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 1997; 77:1077-80.
22. Tsakiris DA, Tschopl M, Jager K, Haefeli WE, Wolf F, Marbet GA. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1999; 142:193-200.
23. Diquelou A, Dupouy D, Gaspin D, Constans J, Sie P, Boneu B, et al. Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions. Thromb Haemost 1995; 74:778-83.
24. Marietta MA. Nitric oxide synthetase structure and mechanism. J Biol Chem 1993; 268:12231-4.
25. Sarkar R, Gelabert HA, Mohiuddin KR, Thakor DK, Santibanez-Gallerani AS. Effect of cigarette smoke on endothelial regeneration in vivo and nitric oxide levels. J Surg Res 1999; 82:43-7.
26. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 1995; 38:87-104.
27. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 1994; 93:2236-43.
28. Avontuur JA, Boomsma F, van den Meiracker AH, de Jong FH, Bruining HA. Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock. Circulation 1999; 99:271-5.
29. De Werra I, Jaccard C, Corradin SB, Chiolero R, Yersin B, Gallati H, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25:607-13.
30. Cicinelli E, Ignarro LJ, Matteo MG, Galantino P, Schonauer LM, Falco N. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women. Am J Obstet Gynecol 1999; 180:334-9.
31. Niu XF, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 1994; 74:1133-40.
32. Simonson MS, Wang Y, Dunn MJ. Cellular signaling by endothelin peptides: pathways to the nucleus. J Am Soc Nephrol 1992; 2:S116-25.
33. Morise T, Takeuchi Y, Kawano M, Koni I, Takeda R. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care 1995; 18:87-9.
34. Mason J, Muller-Schweinitzer E, Dupont M, Casellas D, Mihatsch M, Moore L, et al. Cyclosporine and the renin-angiotensin system. Kidney Int 1991; 32:S28-32.
35. Andert SE, Feichtinger E, Grabenwoger M, Grimm M, Schreiner W, Müller MM. Cyclosporine A increases angiotensin-converting enzyme activity in heart transplant patients. Transplant Proc 1993; 25:2735-7.
36. Ross R, Fuster V. The pathogenesis of atherosclerosis. In: Fuster V, Ross R, Topol EJ (eds.). Atherosclerosis and coronary artery disease. Vol. 1. Philadelphia: Lippincott-Raven, 1996, pp. 441-60.
37. Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1998; 161:4382-7.
38. Wolff B, Burns AR, Middleton J, Rot A. Endothelial cell "memory" of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel-Palade bodies. J Exp Med 1998; 188:1757-62.
39. Müller MM. Organ transplantation. In: Burtis CA, Ashwood ER (eds.). Tietz textbook of clinical chemistry. Philadelphia: W.B. Saunders Company, 1999, pp. 1328-58.
40. Andert SE, Griesmacher A, Zuckermann A, Müller MM. Neopterin release from human endothelial cells is triggered by interferon-gamma. Clin Exp Immunol 1992; 88:555-8.
41. Müller MM, Curtius HC, Herold M, Huber CM. Neopterin in clinical practice. Clin Chim Acta 1991; 201:1-16.
42. Gimbrone MA Jr, Cybulsky MI, Kume N, Collins T, Resnick N. Vascular endothelium. An integrator of pathophysiological stimuli in atherogenesis. Ann N Y Acad Sci 1995; 748:122-31.
43. Cardigan R, McGloin H, Mackie I, Machin S, Singer M. Endothelial dysfunction in critically ill patients: the effect of haemofiltration. Intensive Care Med 1998; 24:1264-71.
44. Verhaar MC, Beutler JJ, Gaillard CA, Koomans HA, Fijnheer R, Rabelink TJ. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. J Hypertens 1998; 16:45-50.